Cargando…

Neuroblastoma Cell Lines Are Refractory to Genotoxic Drug-Mediated Induction of Ligands for NK Cell-Activating Receptors

Neuroblastoma (NB), the most common extracranial solid tumor of childhood, causes death in almost 15% of children affected by cancer. Treatment of neuroblastoma is based on the combination of chemotherapy with other therapeutic interventions such as surgery, radiotherapy, use of differentiating agen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veneziani, Irene, Brandetti, Elisa, Ognibene, Marzia, Pezzolo, Annalisa, Pistoia, Vito, Cifaldi, Loredana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901817/ https://www.ncbi.nlm.nih.gov/pubmed/29805983 http://dx.doi.org/10.1155/2018/4972410

Ejemplares similares

MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma
por: Brandetti, Elisa, et al.
Publicado: (2017)

Enhancement of Neuroblastoma NK-Cell-Mediated Lysis through NF-kB p65 Subunit-Induced Expression of FAS and PVR, the Loss of Which Is Associated with Poor Patient Outcome
por: Brandetti, Elisa, et al.
Publicado: (2021)

The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors
por: Veneziani, Irene, et al.
Publicado: (2019)

Roniciclib down-regulates stemness and inhibits cell growth by inducing nucleolar stress in neuroblastoma
por: Ognibene, Marzia, et al.
Publicado: (2020)

Ezrin interacts with the tumor suppressor CHL1 and promotes neuronal differentiation of human neuroblastoma
por: Ognibene, Marzia, et al.
Publicado: (2020)

Role of GOLPH3 and TPX2 in Neuroblastoma DNA Damage Response and Cell Resistance to Chemotherapy
por: Ognibene, Marzia, et al.
Publicado: (2019)

Neuroblastoma Patients’ Outcome and Chromosomal Instability
por: Ognibene, Marzia, et al.
Publicado: (2023)

The Over-Expression of E2F3 Might Serve as Prognostic Marker for Neuroblastoma Patients with Stage 4S Disease
por: Parodi, Stefano, et al.
Publicado: (2020)

Molecular Genetics in Neuroblastoma Prognosis
por: Lerone, Margherita, et al.
Publicado: (2021)

Immunosuppressive Microenvironment in Neuroblastoma
por: Pistoia, Vito, et al.
Publicado: (2013)

Multiple Genes with Potential Tumor Suppressive Activity Are Present on Chromosome 10q Loss in Neuroblastoma and Are Associated with Poor Prognosis
por: Ognibene, Marzia, et al.
Publicado: (2023)

High Grade of Amplification of Six Regions on Chromosome 2p in a Neuroblastoma Patient with Very Poor Outcome: The Putative New Oncogene TSSC1
por: Ognibene, Marzia, et al.
Publicado: (2021)

CHL1 gene acts as a tumor suppressor in human neuroblastoma
por: Ognibene, Marzia, et al.
Publicado: (2018)

Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas
por: Cantilena, Sandra, et al.
Publicado: (2011)

19p loss is significantly enriched in older age neuroblastoma patients and correlates with poor prognosis
por: Lasorsa, Vito Alessandro, et al.
Publicado: (2020)

Involvement of HMGB1 in Resistance to Tumor Vessel-Targeted, Monoclonal Antibody-Based Immunotherapy
por: Pistoia, Vito, et al.
Publicado: (2016)

Genomic Analysis Made It Possible to Identify Gene-Driver Alterations Covering the Time Window between Diagnosis of Neuroblastoma 4S and the Progression to Stage 4
por: Ognibene, Marzia, et al.
Publicado: (2022)

Intratumoral diversity of telomere length in individual neuroblastoma tumors
por: Pezzolo, Annalisa, et al.
Publicado: (2014)

Proteome Profiling of Neuroblastoma-Derived Exosomes Reveal the Expression of Proteins Potentially Involved in Tumor Progression
por: Marimpietri, Danilo, et al.
Publicado: (2013)

T and NK cells: two sides of tumor immunoevasion
por: Fruci, Doriana, et al.
Publicado: (2013)

Exosomes from Plasma of Neuroblastoma Patients Contain Doublestranded DNA Reflecting the Mutational Status of Parental Tumor Cells
por: Degli Esposti, Chiara, et al.
Publicado: (2021)

Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
por: Melaiu, Ombretta, et al.
Publicado: (2020)

Editorial: Molecular Strategies Aimed to Boost NK Cell-Based Immunotherapy of Cancer
por: Cifaldi, Loredana, et al.
Publicado: (2020)

A Simple, Test-Based Method to Control the Overestimation Bias in the Analysis of Potential Prognostic Tumour Markers
por: Ognibene, Marzia, et al.
Publicado: (2023)

MYCN: from oncoprotein to tumor-associated antigen
por: Pistoia, Vito, et al.
Publicado: (2012)

DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy
por: Cifaldi, Loredana, et al.
Publicado: (2023)

DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection?
por: Cifaldi, Loredana, et al.
Publicado: (2019)

Pediatric Tumors-Mediated Inhibitory Effect on NK Cells: The Case of Neuroblastoma and Wilms’ Tumors
por: Pelosi, Andrea, et al.
Publicado: (2021)

DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells in vitro: a proof-of-concept study
por: Focaccetti, Chiara, et al.
Publicado: (2022)

GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape
por: Caforio, Matteo, et al.
Publicado: (2021)

Identification of neuroblastoma cell lines with uncommon TAZ(+)/mesenchymal stromal cell phenotype with strong suppressive activity on natural killer cells
por: Canzonetta, Claudia, et al.
Publicado: (2021)

Inhibition of natural killer (nk) cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome
por: Cifaldi, Loredana, et al.
Publicado: (2014)

Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma
por: Melaiu, Ombretta, et al.
Publicado: (2020)

Failure of anti tumor-derived endothelial cell immunotherapy depends on augmentation of tumor hypoxia
por: Pezzolo, Annalisa, et al.
Publicado: (2014)

IL-27 Driven Upregulation of Surface HLA-E Expression on Monocytes Inhibits IFN-γ Release by Autologous NK Cells
por: Morandi, Fabio, et al.
Publicado: (2014)

Soluble HLA-G and HLA-E Levels in Bone Marrow Plasma Samples Are Related to Disease Stage in Neuroblastoma Patients
por: Morandi, Fabio, et al.
Publicado: (2016)

Angiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumour-derived interferon-γ
por: Ribatti, D, et al.
Publicado: (2006)

Endothelial and Smooth Muscle Cells from Abdominal Aortic Aneurysm Have Increased Oxidative Stress and Telomere Attrition
por: Cafueri, Giuseppe, et al.
Publicado: (2012)

Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells
por: McNerney, Kevin O., et al.
Publicado: (2020)

The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma
por: Grasso, Silvia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a5ireurk088ir7tmglv7danbd0